Stay updated with breaking news from Antonye Pfaffle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CorMedix (NASDAQ:CRMD – Get Rating) had its price target increased by equities research analysts at JMP Securities from $16.00 to $19.00 in a note issued to investors on Friday, The Fly reports. JMP Securities’ price objective would indicate a potential upside of 327.93% from the company’s current price. A number of other equities analysts have […]
CorMedix Inc. (NASDAQ:CRMD – Get Rating) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,220,000 shares, a growth of 8.3% from the April 15th total of 2,050,000 shares. Based on an average trading volume of 257,500 shares, the short-interest ratio is currently […]
CorMedix Inc. (NASDAQ:CRMD – Get Rating) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 2,220,000 shares, a growth of 8.3% from the April 15th total of 2,050,000 shares. Based on an average trading volume of 257,500 shares, the short-interest ratio is presently […]